Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Xeris Biopharma Holdings, Inc. amended Amendment No. 2 to Credit Agreement and Guaranty with Hayfin Services LLP, as administrative agent, and the lenders parties thereto (effective 2023-01-19).
- Action
- amendment
- Agreement
- credit facility
- Counterparty
- Hayfin Services LLP, as administrative agent, and the lenders parties thereto
- Effective
- 2023-01-19
Exact text from the filing
On January 19, 2023, Xeris Biopharma Holdings, Inc. (the “Company”) entered into Amendment No. 2 to Credit Agreement and Guaranty (“Amendment No. 2”) with Xeris Pharmaceuticals, Inc. (“Xeris Pharma”), the lenders parties thereto (the “Lenders”) and Hayfin Services LLP, as administrative agent for the Lenders (in such capacity, together with its successors and assigns, the “Agent”), to amend that certain Credit Agreement and Guaranty, dated as of March 8, 2022, as amended by Amendment No. 1 to Credit Agreement and Guaranty dated September 29, 2022 (the “Credit Agreement”), by and among the Company, Xeris Pharma, the subsidiary guarantors from time to time parties thereto, the Agent and the Lenders from time to time parties thereto.
View on SEC.gov